Literature DB >> 18177318

Pharmacokinetics of tramadol and o-desmethyltramadol in goats after intravenous and oral administration.

A B de Sousa1, A C D Santos, S G Schramm, V Porta, S L Górniak, J C Florio, H de Souza Spinosa.   

Abstract

The aim of this trial was to implement a method to obtain a tool for analyses of tramadol and the main metabolite, o-desmethyltramadol (M1), in goat's plasma, and to evaluate the pharmacokinetics of these substances following intravenous (i.v.) and oral (p.o.) administration in female goats. The pharmacokinetics of tramadol and M1 were examined following i.v. or p.o. tramadol administration to six female goats (2 mg/kg). Average retention time was 5.13 min for tramadol and 2.42 min for M1. The calculated parameters for half-life, volume of distribution and total body clearance were 0.94+/-0.34 h, 2.48+/-0.58 L/kg and 2.18+/-0.23 L/kg/h following 2 mg/kg tramadol HCl administered intravenously. The systemic availability was 36.9+/-9.1% and half-life 2.67+/-0.54 h following tramadol 2 mg/kg p.o. M1 had a half-life of 2.89+/-0.43 h following i.v. administration of tramadol. Following p.o., M1 was not detectable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18177318     DOI: 10.1111/j.1365-2885.2007.00916.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

1.  Biopharmaceutical profile of tramadol in the dog.

Authors:  M Giorgi; S Del Carlo; G Saccomanni; B Łebkowska-Wieruszewska; V Turini; C Kowalski
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

Review 2.  Analgesia for Sheep in Commercial Production: Where to Next?

Authors:  Alison Small; Andrew David Fisher; Caroline Lee; Ian Colditz
Journal:  Animals (Basel)       Date:  2021-04-14       Impact factor: 2.752

3.  Pharmacokinetic and urine profile of tramadol and its major metabolites following oral immediate release capsules administration in dogs.

Authors:  M Giorgi; S Del Carlo; G Saccomanni; B Łebkowska-Wieruszewska; C J Kowalski
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.